Restoration of the immunocompetence by IL-2 activation and tcr-cd3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients

Journal of Immunotherapy

Volumn 20, Issue 5, 1997, Pages 354-364

  Chen, Yuh Min ^a,b,c   Yang, Wen Kuang ^b,c   Whang Peng, Jacqueline ^b,c   Tsai, Wen Ying ^a   Hung, Yi Mei ^c   Yang, Den Mei ^c   Lin, Wen Chang ^c   Perng, Reury Perng ^a   Ting, Chou Chik ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Lung cancer; Pleural effusion; T cell anergy; Tumor immunity

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 2;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CELL STRAIN K 562; CLINICAL ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DAUDI CELL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; LUNG CANCER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PLEURA EFFUSION; PRIORITY JOURNAL;

EID: 0031463668     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199709000-00004     Document Type: Article

References (26)

1. Stutman O. Immunodepression and malignancy. Adv Cancer Res 1975;22:261-422.
2. Kamo I, Friedman H. Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res 1977;25:271-321.
3. Nelson DS, Nelson M. Evasion of host defenses by tumors. Immunol Cell Biol 1987;65:287-304.
4. Sulitzeanu D. Immunosuppressive factors in human cancer. Adv Cancer Res 1993;60:247-67.
5. Ting CC, Wang J, Hargrove ME. Reversal of multiple-site tumor cell-induced immunosuppression by specific cytokines and pharmacological agents. Immunopharmacology 1995;30:119-30.
6. Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 1990; 248: 1342-8.
7. Abbas AK. Die and let live: eliminating dangerous lymphocytes. Cell 1996;84:655-7.
8. Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987;165:302-19.
9. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-56.
10. Quill H. Anergy as a mechanism of peripheral T cell tolerance. J Immunol 1996;156:1325-7.
11. Chen L, Ashe S, Brady WA, et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992;71:1093-100.
12. Gajewski TF, Renauld J-C, Van Pel A, Boon T. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J Immunol 1995; 154:5637-48.
13. Sundstedt A, Dohlsten M, Hedlund G, Hoi den I, Bjorklund M, Kalland T. Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology 1994;82:117-25.
14. + T cells induces functional but nonproliferative T cell in vivo. Immunology 1994;83:333.
15. Heeg K, Gaus H, Griese D, Bendigs S, Miethke T, Wagner H. Superantigen-reactive T cells that display an anergic phenotype in vitro appear functional in vivo. Int Immunol 1994;7:105-14.
16. Heeg K, Wagner H. Induction of responsiveness in superantigen induced anergic T cells: Role of ligand density and costimulatory signals. J Immunol 1995;155:83-92.
17. Sahn SA. The pleura. Am Rev Respir Dis 1988;138:184-234.
18. Light RW. Pleural diseases. Dis Mon 1992;38:261-331.
19. Chen YM, Yang WK, Whang-Peng J, Kuo BIT, Pemg RP. Elevation of interleukin-10 levels in malignant pleural effusion. Chest 1996;110:433-6.
20. Kung PC, Goldstein G, Reinherz EL, Schlossman SF. Monoclonal antibodies defining distinctive human T cell surface antigens. Science 1979;206:347-9.
21. Brodsky FM, Parham P. Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol 1982;128:129-35.
22. Beverly B, Kang SM, Lenardo MJ, Schwartz RH. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 1992; 6:661-71.
23. Nelson EL, Li X, Hsu FJ, et al. Tumor-specific cytotoxic T lymphocyte response after idiotype vaccination for B-cell, non Hodgkin’s lymphoma. Blood 1996;88:580-9.
24. + T cells. J Exp Med 1996;184:19-29.
25. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996;184:1-8.
26. Go C, Lancki DW, Fitch FW, Miller J. Anergized T cell clones retain their cytolytic ability. J Immunol 1993;150:367-76.